Collegium Pharmaceutical (AllerNaze) Overview

  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • Asset Purch.
  • Financing Rounds
  • 1

Collegium Pharmaceutical (AllerNaze) General Information

Description

AllerNaze is a intra-nasal steroid product. The AllerNaze nasal spray is used in treating nasal itching, sneezing and nasal congestion in patients with allergic rhinitis.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Buildings and Property
Other Industries
Pharmaceuticals
Drug Discovery
Acquirer
Primary Office
  • 780 Dedham Street
  • Suite 800
  • Canton, ME 02021
  • United States
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Collegium Pharmaceutical (AllerNaze) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Collegium Pharmaceutical (AllerNaze)‘s full profile, request access.

Request a free trial

Collegium Pharmaceutical (AllerNaze) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Collegium Pharmaceutical (AllerNaze)‘s full profile, request access.

Request a free trial